Search - tctmd.com

Displaying 121 - 140 of 367

Sort: Relevancy | Date

Presentation THT Abstracts 2024

Effect Of Vagal Nerve Stimulation On Quality Of Life, Functional Capacity, And Left Ventricular Function In Patients With Chronic Heart Failure: An Update On The ANTHEM-HFrEF Pivotal Study Results

Presenter: Marvin Konstam

March 04, 2024

Presentation THT 2024

When to consider AccuCinch

Presenter: Sean P. Pinney

March 04, 2024

Presentation THT 2024

Transcatether Left Ventricular Restoration (TLVR): The AccuCinch Approach

Presenter: Ulrich P. Jorde

March 04, 2024

Presentation THT 2024

Why Treat The Dilated Left Ventricle

Presenter: Daniel Burkhoff

March 04, 2024

Presentation THT 2024

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

Presenter: Michael R. Zile

March 04, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Daily News

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

L.A. McKeown

February 12, 2024

News Daily News

GDMT Rates Low in HFrEF, Particularly in Women

L.A. McKeown

January 30, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

News Features

FDA Clears AI-ECG Screening Tools for CV Care: What’s Next Is Up for Grabs

Yael L. Maxwell

December 14, 2023

News Daily News

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

L.A. McKeown

December 08, 2023

News Opinion CV Team Dispatch

December 2023 Dispatch for the CV Team

L.A. McKeown

December 01, 2023

News Conference News AHA 2023

Seeing Sticker Price for HFrEF Meds Opens Door to Discussions

Caitlin E. Cox

November 14, 2023

News Opinion CV Team Dispatch

November 2023 News Roundup

L.A. McKeown

November 01, 2023

Presentation TCT 2023

Transcatheter Pulmonary Artery Banding In Chronic Heart Failure [HFrEF]: Results From the First-in-Human Study

Presenter: Sean Pinney

October 26, 2023

Presentation TCT 2023

Moderate AS in HFrEF: Time to Treat Is Now

Presenter: Nicolas Van Mieghem

October 24, 2023

Presentation TCT 2023

Mitral Transcatheter Edge-to-Edge Repair for Secondary MR in the Management of HFrEF: Where Does It Fit in?

Presenter: Marianna Adamo

October 24, 2023

Presentation TCT 2023

TCT 982: Invasive Provocative Spasm Testing and Microvascular Testing Revealed True Cause of HFrEF in a Patient with Suspected Sarcoidosis

Presenter: Edward Ha

October 24, 2023

News Conference News HFSA 2023

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

Yael L. Maxwell

October 16, 2023

News Conference News HFSA 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

Todd Neale

October 11, 2023

Advertisement

Effect Of Vagal Nerve Stimulation On Quality Of Life, Functional Capacity, And Left Ventricular Function In Patients With Chronic Heart Failure: An Update On The ANTHEM-HFrEF Pivotal Study Results

When to consider AccuCinch

Transcatether Left Ventricular Restoration (TLVR): The AccuCinch Approach

Why Treat The Dilated Left Ventricle

FDA-Approved But Less Frequently Used Device Therapies to Treat HFrEF: Challenges and Opportunities

March 2024 Dispatch for the CV Team

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

GDMT Rates Low in HFrEF, Particularly in Women

January 2024 Dispatch for the CV Team

FDA Clears AI-ECG Screening Tools for CV Care: What’s Next Is Up for Grabs

Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes

December 2023 Dispatch for the CV Team

Seeing Sticker Price for HFrEF Meds Opens Door to Discussions

November 2023 News Roundup

Transcatheter Pulmonary Artery Banding In Chronic Heart Failure [HFrEF]: Results From the First-in-Human Study

Moderate AS in HFrEF: Time to Treat Is Now

Mitral Transcatheter Edge-to-Edge Repair for Secondary MR in the Management of HFrEF: Where Does It Fit in?

TCT 982: Invasive Provocative Spasm Testing and Microvascular Testing Revealed True Cause of HFrEF in a Patient with Suspected Sarcoidosis

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content